University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

101-120 of 135 results by Hong Kim

Previous  |  1 |  2 |  3 |  4 |  5 |  6 |  7 |  Next

Title: How often do we encounter the signs and symptoms of clonidine overdose?

Category: Toxicology

Keywords: adult clonidine overdose (PubMed Search)

Posted: 3/24/2017 by Hong Kim, MD (Updated: 7/21/2026)

Clinical signs and symptoms of clonidine overdose include CNS depression, bradycardia, and miosis. Other effects include early hypertension, followed by hypotension and respiratory depression, especially in children.

 

Although clonidine overdose in children is well described, frequency of clinical signs/symptoms in adults is not well characterized.

 

Recently, a retrospective study was performed in a hospital in Australia looking at clonidine overdose in adults.  

 

Among isolated clonidine overdose, patients experienced:

  • GCS < 15: 55%
  • GSS < 9: 5%
  • Miosis: 25%
  • Bradycardia (HR< 60): 68%
  • Median HR: 48 (IQR: 40-62)
  • Hypotension (SBP < 90 mmHg): 25%
  • Median LOS: 21 hr (IQR: 11 – 27 hr)
  • Intensive care: 23%
  • No deaths

Bottom line:

  1. The most common symtom of clonidicine overdose was bradycardia
  2. Clonidine overdose results in non-life threatening but prolonged clinical effect in adult.

Show References

Isbister GK et al. Adult clonidine overdose: prolonged bradycarida and central nervous system depression, but not severe toxicity. Clin Toxicol 2017;55:187-192.



Title: Methadone induced hypoglycemia Is there such a thing?

Category: Toxicology

Keywords: methadone overdose, hypoglycemia (PubMed Search)

Posted: 1/26/2017 by Hong Kim, MD

Methadone overdose produces classic signs and symptoms of opioid intoxication - CNS and respiratory depression with pinpoint pupils. However, methadone overdose has also been associated with hypoglycemia – a relatively uncommon adverse effect.

Bottom line:

  • Methadone-induced hypoglycemia can occur, although rare, in an acute overdose.

Show Additional Information

Several case reports have been published over the past years. Recently, a case of refractory hypoglycemia was reported in a woman, without a history of diabetes, after ingesting 250 mL of methadone (18.2 mg/kg).

She required, in additional to naloxone infusion for respiratory depression, dextrose infusion (initially D10 then D20) for 54 hours.

  • Plasma insulin levels were normal.
  • No oral hypoglycemic agents were detected in urine.
  • The exact mechanism of methadone-induced hypoglycemia is unknown.

Incidence of hypoglycemia has also been observed in patient with rapid methadone dose escalation as well as in cancer patient who were started on methadone for pain control with dose-depedent association. 

In a mice study, methadone induced a dose dependent hypoglycemia - 20 mg/kg methadone resulted in decrease in average glucose level of 172 +/- 7 mg/dL to 55 +/- 6 mg/dL. This effect was reversed by naloxone administration. morphine, fentanyl, oxycodone and levorphanol did not produce hypoglycemia.

However, in the case report published in Clinical Toxicology Nov 2016, naloxone infusion did not effect the hypoglycemia. 

Show References

  1. Li AT, Chu FK. A case of massive methadone overdose presented with refractory hypoglycemia. Clin Toxicol 2017 Jan 24:1-3. doi: 10.1080/15563650.2016.1277236. [Epub ahead of print]
  2. Moryl N et al. Hypoglycemia during rapid methadone dose escalation. J Opioid Manag. 2013;9:29-34.
  3. Flory JH et al. Methadone use and the risk of hypoglycemia for inpatients with cancer pain. J Pain Symptoms Manage 2016;51:79-87.
  4. Faskowtiz AJ et al. Methadone-induced hypoglycemia. Cell Mol Neurobiol 2013;33:537-42.
 

 



Title: Risk factors of severe outcome in acute salicylate poisoning

Category: Toxicology

Keywords: salicylate poisoning (PubMed Search)

Posted: 1/13/2017 by Hong Kim, MD (Updated: 7/21/2026)

A small retrospective study of an acute poisoning cohort attempted to identify risk factors for severe outcome in salicylate poisoning.

Severe outcomes were defined as

  1. Acidemia pH < 7.3 or bicarbonate < 16 mEq/L
  2. Hemodialysis
  3. Death

A multivariate analysis of 48 patients showed that older age and increased respiratory rate were independent predictors of severe outcomes when adjusted for salicylate level.

Initial salicylate acid level was not predictive of severe outcome.  

Elevated lactic acid level was also a good predictor of severe outcome in univariate analysis but not in multivariate analysis.

Limitations

  1. Small sample size with single center study
  2. Retrospective study design
  3. Validation study of these predictors is needed.

 

Bottom line

  1. Older age and increases respiratory rate is associated with severe outcome (acidemia, hemodialysis or/and death) in this study.
  2. Data must be interpreted with caution due to small sample and retrospective study design.

Show References

Shively RM et al. Acute salicylate poisoning: risk factors for sever outcome. Clin Toxicol 2017 Jan 9:1-6. doi: 10.1080/15563650.2016.1271127. [Epub ahead of print]



Title: Utility of lactic acid level for diagnosis of cyanide poisoning in smoke inhalation victims

Category: Toxicology

Keywords: cyanide toxicity, lactic acid (PubMed Search)

Posted: 12/30/2016 by Hong Kim, MD (Updated: 12/30/2016)

Smoke inhalation victims (house fires) are at risk of carbon monoxide (CO) and cyanide poisoning (CN). CO exposure/poisoning can be readily evaluated by CO - Oximetry but CN level can be obtained in majority of the hospital.

Lactic acid level is often sent to evaluate for CN poisoning.

 

Bottom line:

  1. Lactatic acid levels should be sent in all smoke inhalation victims.
  2. Elevate lactate > 10 mmol/L is highly suggestive of CN poisoning
    .

 

 

Show Additional Information

In a manuscript published in 1991, N Engl J Med by Dr. FJ Baud is the source of this data.

CN blood levels were measured in 109 residetial fire victims in France prior to any treatment was initiated.

  • 43 fire victims who died had mean blood CN level of 116.4 micromol/L
  • 66 fire victims who survived had mean blood CN level of 21.6 micromol/L
  • Plasma lactate level correlated more closely with blood CN level than blood CO level.
  • Elevated lactate of 10 mmol/L was sensitive (87%) for CN level > 40 micromol/L (defined level of CN toxicity) with specificity of 94% and positive predictive value of 95%.

 

 

Show References

Baud FJ et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991;325:1761-6.



Title: Does a low initial APAP level after an acute APAP overdose useful in identifying ED patient who will not require NAC?

Category: Toxicology

Keywords: acetaminophen overdose, APAP levels (PubMed Search)

Posted: 12/8/2016 by Hong Kim, MD (Updated: 12/9/2016)

Recent study evaluated whether an acetaminophen (APAP) level obtained less than 4-hour post acute ingestion can predict which patient would not require n-acetylcysteine (NAC).  APAP cutoff level of 100 ug/mL was used for analysis. This was a secondary analysis of the Canadian Acetaminophen Overdose Study database (retrospective study). 

 

Bottom line:

  1. If initial APAP level of 100 ug/mL was applied as a cutoff point, it missed 27 patients (N= 1821) who had toxic APAP level at > 4-hour post ingestion that require NAC.  
  2. Only a very low (< 15 ug/mL) or undetectable initial APAP reliably identify (sensitivity 100%) patients who do not require NAC.
  3. Absorption of APAP can be delayed by coingestion of opioids or antimuscarinics.

 

 

Show Additional Information

 

Table 2. Diagnostic accuracy of acetaminophen concentration obtained 2 to 4 hours post-ingestion to identify subsequent potentially toxic concentration measured 4 to 20 hours pos-ingestion.

 

Subsequent 4-hour equivalent [APAP]

[APAP] obtained 2 to 4 hours post-ingestion

>150 ug/mL

< 150 ug/mL

<10

0

89

10-20

2

79

20-50

6

209

50-100

19

249

100-150

46

253

150-200

161

195

200-300

276

46

300-450

148

5

>450

38

0

 

Show References

Yarema MC, et al. Can a serum acetaminophen concentration obtained less than 4 hours post-ingestion determine which patients do not rquire treatment with acetylcysteine? Clin Toxicol 2016; online early: doi: 10.1080/15563650.2016.1247959 



Title: Management of heroin overdose patients in prehospital and ED setting: How long do they need to be observed?

Category: Toxicology

Keywords: heroin overdose, observation period, bystander naloxone (PubMed Search)

Posted: 11/17/2016 by Hong Kim, MD (Updated: 11/17/2016)

Recently a review paper was published regarding the duration of observation in heroin overdose patients who received naloxone.

It made several conclusions regarding heroin overdose:

  1. Treat (naloxone) and release in a prehospital setting may be safe.
  2. Short observation period (minimum of 1 hour) for heroin OD patients who were treated in the ED may be safe.
  3. Bystander and first responder naloxone administration is effective and safe.

It should be pointed out that this is a review paper of limited number of articles with variable quality. Additionally, the clinical history of “heroin use” may be unreliable as fentanyl and novel synthetic opioids are also sold as “heroin.” Providers should exercise appropriate clinical judgement when caring for these patients. 

Show Additional Information

The paper attempted to answer following questions

  1. In prehospital setting, does a heroin OD patient who was resuscitated with naloxone require transportation to the ED and what are the medical risk of refusing transport to the ED?

Review conclusion (8 articles): Patients were safe to release if they had normal mentation and vital signs. Mortality from recurrent heroin toxicity was 0.13% - 0.49% within 24 to 48 hours after naloxone administration.

  1. If heroin OD patient is treated in the ED, how long should the patient be observed before they are deemed safe to be discharged?

Review conclusion (5 articles):  Wide range of observation period is reported. One study showed that 1-hour observation is sufficient when patients have normal ambulation, normal vital signs and GCS of 15 after 1-hour observation.

  1. How effective is naloxone administration by bystander and first responder for heroin overdose and what are the risk in heroin users following naloxone administration by lay bystanders or first responder?

Review conclusion (15 articles): Rate of successful reversal ranged from 83% to 100% in the literature. Bystander and first responder naloxone administration is associated with minimum risk outside of mild opioid withdrawal symptoms.

The conclusion of this review paper only applies to heroin intoxication, a short-acting opioid. However, it can be difficult to discern clinically what type of opioid is causing the clinical toxicity as “heroin” may actually be other opioids such as fentanyl or other novel synthetic opioids (e.g. U-47700). 

Show References

 

Clin Toxicol (Phila). 2016 Nov 16:1-7. [Epub ahead of print]

Do heroin overdose patients require observation after receiving naloxone?

Willman MW1, Liss DB1, Schwarz ES1, Mullins ME1.

 



Title: Buprenorphine/naloxone (Suboxone) exposure in pediatric population

Category: Toxicology

Keywords: buprenorphine exposure, pediatrics, retrospective study (PubMed Search)

Posted: 10/27/2016 by Hong Kim, MD

Recently, a retrospective study of unintentional buprenorphine/naloxone exposure among pediatric population was published. All patients were evaluated by toxicologists at the time of initial hospital presentation (or transfer) at the study center.

 

Bottom line

  • 83% and 80% of the patients experienced respiratory and CNS depression, respectively.
  • Majority of the patients became symptomatic within 8 hours of exposure (range not available).
  • Naloxone reversed respiratory depression. Median dose for single naloxone dose: 0.09 mg/kg; median dose for multiple naloxone doses: 0.19 mg/kg.
  • The reported “ceiling effect” on respiratory depression in adult does not exist in pediatric population.
  • The optimal time of observation is unclear but it is prudent to observe pediatric buprenorphine exposure for up to 24 hours.

Show Additional Information

A retrospective study of single center/referral center’s toxicology consultation service.

88 patients were included. (median age: 24 months [range: 10 to 77 months]). Majority were transferred from other hospitals.

Sources of the medication were

  1. Primary caregiver (65%)
  2. Other relatives (17%)
  3. Parent’s friends (14%)

 

Clinical effects

  • Respiratory depression: 83%
  • SpO2 < 93%: 28%
  • CNS depression: 80%
  • Miosis: 77%
  • Emesis: 45%
  • Agitation: 5%

 

Naloxone

  • 55% of the patients received naloxone
  • Two patients received naloxone 8 – 12 hours and >12 hours after exposure due to respiratory depression.

The median hospital stay was 22 hours (7 - 248 hours).

  • 41% (n = 36) were admitted to ICU.
  • The reported exposure dose was the only factor that was significantly associated with length of stay in a multivariate analysis (other variables: sex, age and time to presentation)

 

 

Show References

Clin Toxicol (Phila). 2016 Oct 19:1-6. [Epub ahead of print]

Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center.

Toce MS1, Burns MM1,2, O'Donnell KA1,3.


Title: Experts consensus recommendation for CCB poisoning 2016

Category: Toxicology

Keywords: CCB poisoning (PubMed Search)

Posted: 10/13/2016 by Hong Kim, MD

US, Canadian and European critical care and toxicology societies recently published a consensus recommendation is the management of CCB poisoning.

Bottom line:

1. First line therapy remains unchanged: IV calcium, atropin, high-dose insulin (HIE) therapy, vasopressor support (norepinephrine and/or epinephrine).

2. Refractory to first line therapy: increase HIE, lipid-emulsion, transvenous pacemaker

3. Refractory shock, periarrest or cardiac arrest: Above (#1 & #2) plus ECMO if available.

Show Additional Information

Overall, there has not been a signficant changes to the current management of CCB poisoning. However, there is a nice flow chart of the algorithm/recommendation in the article. The authors note that the "level of evidenc was very low" for all intervention.

Briefly:

A. asymptomatic patients

  1. Observation up to 24 hours for potentially toxic ingestion
  2. GI decontamination

B. First line therapy

  1. IV calcium
  2. atropine in symptomatic bradycardia or conduction disturbance
  3. high-dose insulin therapy
  4. norepineprhine and/or epinephrine
  5. In the presence of cardiogenic shock: epinephrine or dobutamine

C. Refractory to first line therapy

  1. Incremental increase of high-dose insulin therapy (up to 10 unit/kg/hr) in presence of myocardia dysfunction
  2. IV lipid-emulsion therapy
  3. pacemaker in the presence of unstable bradycardia or high-grade AV block

D. Refratory shock or periarrest

  1. incremental increase of high-dose insulin therapy
  2. IV lipid-emulsion therapy if not administered
  3. pacermaker in the presence of unstable bradycardia or high-grade AV block in absence of myocardial dysfunction if not initated previously
  4. ECMO, if available

E. Cardiac arrest

  1. IV calcium
  2. ACLS guided resuscitation
  3. IV lipid-emulsion therapy
  4. ECMO

Show References

St-Onge, M et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med 2016 (http://journals.lww.com/ccmjournal/Abstract/publishahead/Experts_Consensus_Recommendations_for_the.96757.aspx)



Title: Variation in naloxone dose recommendation for opioid intoxication among medical specialties: Is there a "right" dose?

Category: Toxicology

Keywords: naloxone, opioid intoxication (PubMed Search)

Posted: 9/15/2016 by Hong Kim, MD

Naloxone has been used to reverse opioid-induced respiratory depression for decades. The “standard” dose of opioid intoxication has been 0.4 mg.  However, over the past decade, initial naloxone dose for opioid intoxication has evolved to recommend a lower initial dose (0.04 – 0.05 mg).

 

A recent article by Connors et al. reviewed 25 medical resources (internet, medical texts and study guides) of different medical specialties (internal medicine, medical toxicology, emergency medicine, pediatrics, anesthesiology, pain medicine and general medicine)

 

Findings:

  • 12 medical resources (48%) recommend using 0.05 mg or less IV as an initial dose.
  • 9 medical resources (36%) recommend using 0.4 – 0.5 mg or higher as an initial dose.
  • Maximum dose also ranged widely from 2 to 20 mg.

 

Recent editions of emergency medicine text (Rosen’s and Tinitinalli) recommend using 0.04 – 0.05 mg IV in ED patients with history of opioid dependence. Higher doses of naloxone are recommended for non-opioid dependent/apneic patients.

 

However, history of opioid dependence is difficult to obtain in patients with opioid induced CNS/respiratory depression.

 

Administering 0.4 mg or higher dose may/can acute agitation or opioid withdrawal symptoms that can utilize more ED resources to calm agitated patient/management of withdrawal. Thus it may be prudent to use low-dose strategy (0.04 mg IV with titration) to minimize the risk of precipitating naloxone-induced opioid withdrawal/agitation.

 

Bottom line:

In opioid-induced respiratory depression/apneic patients:

  1. Ventilate with bag-valve mask for apnea/hypoxia
  2. Administer naloxone: 0.04 mg IV every 2 – 3 min until reversal of respiratory depression/hypoxia is achieved.

To make 0.04 mg naloxone solution:

  • Dilute 1 mL of 0.4 mg naloxone with 9 mL normal saline in 10 mL syringe. 

 

Show References

Connors NJ, Nelson LS. The evolution of recommneded naloxone dosing for opioid overdose by medical specialty. J Med Toxicol 2016;12:276-281.



Title: Atypical antipsychotics: are they truly safer than typical antipsychotics?

Category: Toxicology

Keywords: atypical antipsychotic toxicity (PubMed Search)

Posted: 9/8/2016 by Hong Kim, MD (Updated: 7/21/2026)

Antipsychotic as a class has diverse range of toxicity. The atypical (2nd generation) antipsychotics are considered to possess less toxicologic manifestation compared to the typical (1st generation) antipsychotics - lower K channel blockade and minimum Na channel blockade properties. However, select atypical antipsychotics overdose can results in significant morbidity in addition to sedation.

 

Alpha-1 blockade (hypotension)

  • Clozapine
  • Olanzapine
  • Quetiapine
  • Risperidone
  • Ziprasidone

 

Antimuscarinic effect (anticholinergic toxicity)

  • Clozapine
  • Olanzapine
  • Quetiapine

 

Delayed rectifier K channel blockade (QT prolongation)

  • Ertindole
  • Ziprasidone

 

Bottom line:  Although lethal overdose from atypical antipsychotics are rare, they can result in significant clinical toxicity when ingested alone or in combintation with other classes of medications.

 

 



Title: Lethal in small dose or single pill in pediatric population (age < 5 years old)

Category: Toxicology

Keywords: One pill killers, pediatric (PubMed Search)

Posted: 8/18/2016 by Hong Kim, MD (Updated: 8/18/2016)

In pediatric population, small dose or single pill ingestion can potential result in severe or lethal toxicity.

Clinicians should be mindful of potential toxicity following xenobiotic exposure (below) in pediatric population, especially under the age of 5 years old, even if the patient may initially appear asymptomatic.

  • Benzocaine
  • B-adrenergic antagonist (sustained release)
  • Calcium Channel blockers (sustained release) 
  • Camphor
  • Clonidine
  • TCAs
  • Diphenoxylate/atropine (Lomotil)
  • Toxic alcohol (methanol or ethylene glycol)
  • Methylsalicylate
  • MAO-Is
  • Opioids
  • Phenothiazines
  • Quinine or chloroquine
  • Sulfonylureas
  • Theophylline

 

Suspected ingestion of above medications/xenobiotics may warrent observation up to 24 hours in asymptomatic pediatric population.

 

 



Title: Are synthetic opioids next novel designer drugs of abuse in the U.S?

Category: Toxicology

Keywords: novel synthetic opioid, U-47700 (PubMed Search)

Posted: 8/3/2016 by Hong Kim, MD (Updated: 7/21/2026)

Recently, there have been several news reports regarding the emergence of synthetic opioids in the U.S. and Canada. There are multiple synthetic opioids that have been identified as potential agents of abuse including W-18, U-47700, fentanyl derivatives, AH-7921 and MT-45. These compounds share a similar story with synthetic cannabinoid where they were synthesized for research purpose or by pharmaceutical companies but were not marketed. They are often sold as “research chemicals” over the internet.

In July 2016, three case reports have been published regarding several cases of U-47700 intoxication in San Diego, CA and Dallas, TX.

  • Dallas, TX: A couple in their 20’s purchased U-47700 on the internet believing it to be “synthetic cocaine.” They both suffered CNS and respiratory depression after insufflation. Naloxone was not administered in both cases. The man was intubated while the woman was awake at time of presentation to the ED. U-47700 exposure was confirmed by liquid chromatography/tandem mass spectrometry.

 

  • San Diego, CA: a 22 year old man with history of heroin abuse was found unresponsive and apneic (4 breaths per minute and pulse oximetry of 60%). He received naloxone 2 mg IV which completely reversed his CNS and respiratory depression. He admitted to purchasing U-47700 on the internet and its use prior to being found unresponsive. U-47700 exposure was confirmed using liquid chromatography/mass spectrometry.

 

  • Central CA: 41 year old woman presented with CNS depression and pinpoint pupils after ingesting 3 tablets of “Norco” purchased from the street.  Her intoxication was completely reversed with naloxone 0.4 mg IV and discharged after 4 hour observation. Fentanyl and U-47700 was detected in serum blood test.

It is unknown if currently available heroin is cut with above mentioned synthetic opioids. Like other opioid receptor agonists, administration of naloxone will likely reverse the opioid toxidrome. But clinical experience in reversing synthetic opioids intoxication with naloxone is limited.  

 

Bottom line:

Irrespective of whether an ED patient is exposed to synthetic opioids or "traditional" opioids of abuse (prescription opioid pain medication or heroin), the management of opioid intoxication management remains unchanged for respiratory depression. 

  1. Airway management: bag-valve assisted ventilation if needed
  2. Naloxone administration (initial dose: 0.04 to 0.4 mg IV) with titration as needed. 
  • naloxone's clinical duration of effect ranges from 30 to 90 minutes.

Show References

  1. Domanski K et al. Two cases of intoxication with new synthetic opioid, U-47700. Clin Toxicol (Phila). 2016 Jul 19:1-5 [Epub ahead of print]
  2. Schneir A et al. Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class. Clin Toxicol (Phila) 2016July 22:1-4 [Epub ahead of print]
  3. Armenian P et al. Fentanyl and a novel synthetic opioid U-47700 masquerading as street “Norco” in Central California: A case report. Ann Emerg Med 2016. Jul 20. pii: S0196-0644(16)30292-X. doi: 10.1016/j.annemergmed.2016.06.014. [Epub ahead of print]


Title: Laundry detergent pods exposure - the hidden danger.

Category: Toxicology

Keywords: Pediatric exposure, laundry detergent pods (PubMed Search)

Posted: 6/23/2016 by Hong Kim, MD

Laundry detergent pods were introduced in 2012 to make washing clothes more "convenient." Since then, pediatric exposures to laundry detergent pods have increased as the use of these detergent pods have become more common in homes. Like other household chemical exposure, small, colorful candy like appearances of laundry detergent pods can attract the attention of < 3 years old children resulting in unintentional exposure due to curiosity or taste.

Most frequent clinical effects (2013 - 2014 national poison center data) from exposure to detergents in general (laundry detergent pods and nonpods & dishwasher detergent):

  • GI: nausea & vomiting: 29.1%
  • Cough/choking: 8.3%
  • Ocular irritation/pain: 5.6%
  • Red eye/conjunctivitis: 3.4%
  • Drowsiness/lethargy: 2.8%

Laundry detergent pod vs. nonpods:

  • Higher referral to health care facility: 17.4% vs. 4.7%
  • Higher odds of experiencing > 1 clinical effects (OR: 3.9; 95% CI: 3.7 4.1)
  • Higher odds of hospital admission (OR: 4.8; 95% CI: 4.0 5.8)
  • Higher odd of intubation (OR: 6.9; 95% CI: 3.5 13.6)

Laundry detergent pods (only) also resulted in following:

  • Coma: 17 cases
  • Respiratory arrest: 6 cases
  • Pulmonary edema: 4 cases
  • Cardiac arrest: 2 cases

Cases of caustic exposure-like injuries have also been reported (corneal abrasion and esophageal injury)

Bottom line:

Pediatric laundry detergent (nonpods) exposures usually have self-limited symptoms. However, laundry detergent pod exposure can cause more serious clinical effects that may require hospitalization.

Show References

  1. Smith E, Liebelt E, Nogueira J. Laundry detergent pod ingestions: is there a need for endoscopy? J Med Toxicol. 2014 Sep;10(3):286-91. doi: 10.1007/s13181-014-0414-3.
  2. Valdez AL, Casavant MJ, Spiller HA, Chounthirath T, Xiang H, Smith GA. Pediatric exposure to laundry detergent pods. Pediatrics. 2014 Dec;134(6):1127-35. doi: 10.1542/peds.2014-0057. Epub 2014 Nov 10.
  3. Whitney RE1, Baum CR, Aronson PL. Diffuse corneal abrasion after ocular exposure to laundry detergent pod. Pediatr Emerg Care. 2015 Feb;31(2):127-8. doi: 10.1097/PEC.0000000000000244.


Title: Loperamide high more than a fix for diarrhea.

Category: Toxicology

Keywords: loperamide, opioid alternative, cardiac toxicity (PubMed Search)

Posted: 6/15/2016 by Hong Kim, MD (Updated: 7/21/2026)

Loperamide is a peripheral mu-opioid receptor agonist that is found in over the counter anti-diarrheal medication. Following the trend of opioid abuse epidemic, loperamide has been promoted on online drug-use forum as a treatment for opioid withdrawal and as a possible alternative to methadone.  At the same time, recreational use of loperamide has been increasing as an opioid alternative. Unlike therapeutic use of loparamide (2 – 4 mg), loraparmide abusers take supratherapeutic doses (e.g. 50 – 100 mg) to penetrate the CNS to produce opioid effects.  

 

In published case reports, loperamide caused cardiac Na channel blockade (similar to TCA and bupropion) and K channel blockade, resulting in EKG changes including QRS interval > 100 msec with terminal R wave in aVR and QTc prolongation, respectively. Loperamide associated death has also been reported (autopsy finding), although the exact cause of death was not determined.

 

It is unclear if administration of NaHCO3 can reverse the cardiac Na channel blockade as in TCA and bupropion as the clinical experiences have been limited.

 

Bottom line:

  • Clinicians should be aware of potentially lethal cardiac toxicity of loperamide abuse (Na and K channel blockade).

Show References

  1. Wightman RS et al. Not your regular high: cardiac dysrhythmias caused by loperamide. Clin Toxicol 2016;54:454-458.
  2. Eggleston W et al. Loperamide abuse associated with cardiac dysrhythmia and death. Ann Emerg Med 2016 Apr 26. pii: S0196-0644(16)30052-X. doi: 10.1016/j.annemergmed.2016.03.047. [Epub ahead of print]


Title: Don't eat that "wild garlic!" -- Colchicine toxicity.

Category: Toxicology

Keywords: colchicine toxicity (PubMed Search)

Posted: 2/19/2016 by Hong Kim, MD

Colchicine is an alkaloid compound found in Colchicum autumnale that is often mistaken by foragers as wild garlic (Allium ursinum). Unintentional ingestion wild garlic or therapeutic misadventures among elderly population with history of gout often result in unintentional toxicity.

 

It is a potent inhibitor of microtubule formation and function involved in cell division and intracellular transport mechanism. Thus toxicity is related to diffuse cellular dysfunction of all major organs and results in significant morbidity and mortality.

 

Colchicine toxicity occurs in three phases:

 

Phase

Time

Signs and symptoms

Therapy

I

0 – 24 hr

·  Nausea, vomiting, diarrhea

·  Salt and water depletion

·  Leukocytosis

·  Antiemetic

·  GI decontamination

·  IV fluids

·  Observation for leukopenia

II

1 – 7 days

·  Sudden cardiac death (24 – 48 hr)

·  Pancytopenia

·  Acute kidney injury

·  Sepsis

·  Acute respiratory distress syndrome

·  Electrolyte imbalance

·  Rhabdomyolysis

·  Resuscitation

·  G-CSF

·  Hemodialysis

·  Antibiotics

·  Mechanical ventilation

   ·  Electrolyte repletion

III

>7 days

·  Alopecia (2-3 weeks later)

· Myopathy, neuropathy, myoneuropathy.

 

 

Management

  • Primarily supportive care as no antidote is available.
  • ICU admission due to risk of sudden cardiac death in symptomatic patients.
  • Patients who does not manifest GI symptoms within 8 -12 hr are unlikely to be significantly poisoned.


Title: Pediatric lead exposure and poisoning (e.g. Flint, MI)

Category: Toxicology

Keywords: lead poisoning, children (PubMed Search)

Posted: 1/21/2016 by Hong Kim, MD

Lead is a ubiquitous metal in the environment partly due to decades of using leaded gasoline (organic lead) and lead-based paint (inorganic lead). Outside of occupational exposure, children are disproportionately affected from environmental lead exposure.

 

Common route of exposure are:

  1. Ingestion (common in children): soil, water, lead-based paint chips, toys, certain folk remedies.
    • Absorption: adult: 3 – 10% vs. children: 40 – 50%
  2. Inhalation (mostly occupational exposure): lead dust
    • Absorption: 30 – 40%
  3. Dermal (minor): cosmetic products
    • Absorption: < 1%

 

Majority of the absorbed lead are stored in bone (years) > soft tissue (months) > blood (30-40 days) (half-life). Thus blood lead level does not accurately reflect the true body lead burden.

 

Incidence of elevated blood lead level (EBLL > 5 microgram/dL) in children increased from 2.9 to 4.9% in Flint, MI before and after water source change. In the area with the highest water lead level, the incidence increased by 6.6%.

 

Clinical manifestation in children

Clinical severity

Typical blood lead level (microgm/dL)

Severe

  • CNS: encephalopathy (coma, seizure, altered sensorium, ataxia, apathy, incoordination, loss of developmental skills, cranial nerve palsy, signs of increased ICP
  • GI: persistent vomiting
  • Heme: anemia

> 70 – 100

Mild to moderate

  • CNS: hyperirritable behavior, intermittent lethargy, decrease interest in play, “difficult” child
  • GI: intermittent vomiting, abdominal pain, anorexia

50 – 70

Asymptomatic

  • CNS: impaired cognition, behavior, balance, fine-motor coordination
  • Misc: impaired hearing or growth

> 10

 

Evaluation for lead poisoning

  1. Blood lead level (BLL)
  2. CBC: hypochromic microcytic anemia, basophilic stippling
  3. Imaging: abdominal XR – check for foreign bodies in GI tract; long-bone XR – lead lines

 

Management of children with EBLL

  1. Removal from exposure
  2. Environmental investigation/intervention (BLL: 15 - 44 ug/dL)
  3. Chelation
    • Asymptomatic (BLL: 45 – 69 ug/dL): Succimer (PO)
    • Symptomatic (BLL: > 70 ug/dL): Dimercaprol (IM) and CaNa2EDTA (IV)

Show References

  1. Dapul H, Laraque D. Lead poisoning in children. Advances in pediatrics 2014;61:313-333.
  2. Hanna-Attisah M. et al. Elevated blood lead levels in children associated with the Flint drinking water crisis: a spatial analysis of risk and public health response. AM J Public Health 2016;106:283-290.
  3. Goldfrank's Toxicologic Emergencies 10th ed.

 



Title: Nicotine poisoning from liquid nicotine ingestion

Category: Toxicology

Keywords: e-cigarettes, liquid nicotine, nicotine toxicity (PubMed Search)

Posted: 11/19/2015 by Hong Kim, MD

Electronic cigarettes have been gaining popularity in the U.S. as a smokeless delivery system for nicotine. These devices require liquid nicotine (e-liquid) that are vaporized and inhaled (vaping).

 

E-liquid can have nicotine concentration as high as 100 mg/mL, which are diluted prior to use. When ingested in high concentration and in sufficient volume (1 vial = 15 mL) patients can develop significant nicotinic toxicity.  Recently a case of cardiac arrest has been reported after ingesting two 15 ml vial (100 mg/mL).

 

Nicotine mimics the effects of acetylcholine (Ach) release by binding to nicotinic receptors located in:

  • Brain
  • Spinal cord
  • Autonomic ganglia
  • Adrenal medulla
  • Neuromuscular junction
  • Chemoreceptors of carotid/aortic bodies

 

Clinical manifestation of toxicity (similar to cholinergic toxidrome) is biphasic with early central stimulation followed by depression. (see table below)

 

GI

Respiratory

Cardiovascular

Neurologic

Early (1 hr)

Nausea

Vomiting

Salivation

Abdominal pain

Bronchorrhea

Hyperpnea

Hypertension

Tachycardia

Pallor

Agitation

Anxiety

Dizziness

Blurred vision

Headache

Hyperactivity

Tremors

Fasciculation

Seizures

Late

(0.5-4 hr)

Diarrhea

Hypoventilation

Apnea

Bradycardia

Hypotension

Dysrhythmias

Shock

Lethargy

Weakness

Paralysis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Management: There is no specific antidote or reversal agent. The management of nicotine toxicity focuses on organ-specific dysfunction. 

e.g. bronchorrhea = atropine; apnea = intubation; seizure = benzodiazepine.

Show References

  1. Chen BC et al. Death following intentional ingestion of e-liquid. Clin Toxicol 2015;53:914-916.
  2. Kim JW et al. Liquid nicotine toxicity. Pediatr Emer Care 2015;31:517-524.


Title: Utility of CT abdomen/pelvic (with or without PO contrast) to identify body stuffer and body packers.

Category: Toxicology

Keywords: body stuffer, body packer, CAT Scan (PubMed Search)

Posted: 10/15/2015 by Hong Kim, MD

Toxicity due to body packing and body stuffing can be a significant concern due to unknown quantity and/or substance that was ingested.

  • Body stuffers usually ingest small quantities of poorly wrapped illicit substance (intended for sale) to evade law enforcement.
  • Body packer ingests large quantities of well-packaged illicit substance for trafficking purpose. Rupture of these packets can potentially result in fatal toxicity.

A recent prospective observational case series compared the utility of CT abdomen/pelvis with and without PO contrast in identifying the ingested packets.

The gold standard comparison: surgical removal or expulsion of packets.

All patients received CT abd/pelvis with and without PO contrast.

A. Body stuffers (n = 24)

CT w/ PO contrast:

  • Positive: 7 (sensitivity 29.2%)

  • Negative: 17  

CT w/o PO contrast:

  • Positive: 9 (sensitivity 36.5%)

  • Negative: 15

All 24 patients passed ingested packets

B. Body packers (n= 11)

CT w/ PO contrast

  • Positive: 6 (sensitivity 60%)
  • Negative: 5

CT w/p PO contrast

  • Positive: 7 (sensitivity 70%)
  • Negative: 3

10 patients expulsed packets; one patient did not have any packets.

Conclusion

  • CT without PO contrast was better at identifying the ingested packets in both body stuffers and packers.

Bottom line:

  • CT abdomen/pelvis has limited clinical utility in identifying the packets (presence) among body stuffers. If symptomatic, appropriate supportive care should be initiated
  • Among packers who may experience life-threatening toxicity from the leakage/rupture of the packets, CT may be helpful to confirm the presence of packets and to follow the progress of expulsion of packets.
  • Caution should be exercised as CT did not identify packets (body stuffer or packers) in all patients in this case series.

Show References

Shahnazi M et al. Comparison of abdominal computed tomography with and without oral contrast in diagnosis of body packers and body stuffers. Clin Toxicol 2015;53:596-603.



Title: Toxicological etiology of patient with flushed skin .

Category: Toxicology

Keywords: flushed skin (PubMed Search)

Posted: 9/16/2015 by Hong Kim, MD (Updated: 7/21/2026)

 

Monosodium glutamate

  • Rapid onset 30 min and lasts about 1 hour
  • May accompanied with headache & chest pain.
  • No associated GI sx.
  • History of eating Chinese fodd. AKA "Chinese restaurant syndrome"

 

Metabisulfites (Na sulfite, Na/K bisfulfite, Na/K metabisulfite, etc.)

  • Food preservatives found in dried fruit, wine, molasses, sauerkraut, etc.
  • Bronchospasm – asthma like, headache, mild hypotension can occur
  • Most significant reaction in people with asthma/allergies
  • History of trying to eat "healthy"

 

Tyramine reaction

  • Mostly among patients taking MAO inhibitors
  • Source of tyramine (food): fermented, pickled product, avocado, chocolate, etc.

 

Niacin

  • Burning warm sensation to body
  • Often used for sexual enhancement, elevated cholesterol and beating drug urine screens

 

Trichloroethylene

  • Occupational exposure – AKA “Degreaser’s flush”
  • Facial flushing, head pressure, lacrimation & blurred vision may occur
  • Require several weeks of exposure prior to symptoms

 

Scrombroids

  • Occurs after a “fish meal” (e.g. dark meat fish - tuna)
  • Associated with GI symptoms (nausea, vomiting, diarrhea)
  • Histamine related reaction due to poor refrigeration after catching fish.

 

Hydroxocobalamin

  • Antidote for CN poisoning
  • Skin become red after administration due to its color (red)


Title: Body stuffers how long should they be observed in the ED?

Category: Toxicology

Keywords: body stuffers, observation period (PubMed Search)

Posted: 8/20/2015 by Hong Kim, MD (Updated: 7/21/2026)

People who hide illicit drugs can be classified in to three different types.

 

1.     Body stuffers – people who ingest drugs that are poorly wrapped to “eliminate” evidence from police – e.g. street dealers.

2.     Body packers – people who ingest large amounts of “well” packed drug packets to transport drugs (usually internationally) – aka “mule.”

3.     Body pushers – people hiding drugs in rectum or vagina.

 

Body stuffers are more frequently encountered in local ED compared to body packers. Stuffers can become symptomatic as the ingested drugs (cocaine, heroin, amphetamines) are often poorly wrapped (e.g. in plastic bag/wrap, cellophane paper, aluminium oil, etc.).

 

Recent retrospective article looked at the utility of 6-hour observation period in the ED as a management strategy for body stuffers. (n=126)

 

Characteristics

1.     Ingested drugs (self-reported): heroin (48%), cocaine (46%), other drugs [cannabis, MDMA, diazepam, methamphetamine] (16%), unknown (8%)

 

2.     Time of ingestion to ED presentation

  • < 2 hr: 58%
  • 2-6 hr: 10%
  • > 6 hr: 7%

 

Clinical findings

76% of the patients experience clinical signs of toxidrome at time of presentation.

Most common findings:

  • Hypertension: 30%
  • Tachycardia: 20%
  • Agitation: 16%

Patients who ingested heroin were more symptomatic vs. cocaine (87% vs. 70%)

 

Patients were discharged:

  • Within 6 hr: 72%
  • Between 6 – 12 hr: 10%
  • Between 12-24 hr: 10%
  • > 24 hr: 8%

 

Conclusion

  • Patients developed new or worsening drug toxicity within 6 hr of presentation
  • Majority of patients were discharged within 6 hr.
  • Asymptomatic patients at ED presentation should be observed for 6 hr.

Show References

Yamamoto T et al. Management of body stuffers presenting to the emergency department. Europ J Emerg Med. May 8 [Epub ahead of print] PDIM: 25969343



Previous  |  1 |  2 |  3 |  4 |  5 |  6 |  7 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map